WiCell Celebrates Dr. Tenneille Ludwig's 2024 ISSCR Public Service Award for Leadership in Developing Stem Cell Research Standards
PRESS RELEASE
Madison, WI – WiCell, a leader in stem cell research and technology, is proud to announce that Dr. Tenneille Ludwig, Senior Scientist and Director of the WiCell Stem Cell Bank, has been honored as co-recipient of the prestigious 2024 ISSCR Public Service Award along with University of Sheffield Emeritus Professor, Peter Andrews. This award by the International Society for Stem Cell Research (ISSCR), recognizes Dr. Ludwig's significant contributions to the development of the ISSCR Standards for Human Stem Cell Use in Research.
The ISSCR Public Service Award is a testament to Dr. Ludwig's leadership and dedication in co-chairing the ISSCR committee that developed the standards. This initiative, a collaboration between experts in the field, has set a new benchmark for rigor and reproducibility in preclinical research, propelling the advancement of therapies for patients worldwide.
ISSCR President Amander Clark, Ph.D., praised Dr. Ludwig's efforts, stating, "The development of international standards for stem cell research was a groundbreaking, two-year journey adeptly led by Tenneille and Peter. The result of this international collaboration is a highly impactful initiative that sets the standard for rigor and reproducibility."
Expressing her gratitude, Dr. Ludwig said, "I am honored and humbled to receive this award. I am deeply grateful to the ISSCR for their vision, and to Peter and all the dedicated collaborators, editors, and reviewers for unselfishly giving of their time and expertise throughout the developmental process. Our collaborative work on the Standards initiative highlights the guiding principles of rigor and transparency in research, and their importance in driving the field forward."
Robert Drape, CEO of WiCell, added, "Dr. Ludwig's contributions and expertise in the field of pluripotent stem cell research have been instrumental in delivering on WiCell’s mission to support regenerative medicine by promoting best practices in cell banking and characterization. Her leadership in developing these critical standards exemplifies WiCell’s dedication to quality and advancing science for the betterment of humanity."
Dr. Ludwig's career at WiCell reflects her unwavering commitment to quality, collaboration, and ethical integrity in stem cell research. As the world leader in cell banking, characterization, testing, and distribution of stem cell lines, WiCell continues to support regenerative medicine and cell and gene therapy globally.
For more information about WiCell and Dr. Tenneille Ludwig’s contributions to stem cell research, please visit wicell.org.
About WiCell (wicell.org)
Headquartered in Madison, Wisconsin, WiCell is a supporting organization of the University of Wisconsin–Madison, a world leader in the area of human pluripotent stem cell research. Established in 1999 to advance stem cell technologies, our mission extends beyond providing high-quality stem cell lines and characterization services. We are dedicated to advancing regenerative medicine and cell and gene therapy globally. Through promoting best practices in cell banking and characterization, we aim to support groundbreaking research and clinical applications. Our efforts—rooted in a commitment to quality, innovation, and collaboration—underscore our desire to support the scientific community as your lab partner.
Download a pdf copy of this release.
